Gene · 6580
Papers3,731
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,731
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Rosace: a robust deep mutational scanning analysis framework employing position and mean-variance shrinkage. | Genome Biol | 2024 | 38789982 | PubTator, text mining | PubMed |
| Mechanisms of Sorafenib Resistance in HCC Culture Relate to the Impaired Membrane Expression of Organic Cation Transporter 1 (OCT1). | J Hepatocell Carcinoma | 2024 | 38741679 | PubTator, text mining | PubMed |
| Association of the Reduced Function Met420del Polymorphism of SLC22A1 with Metformin-Induced Gastrointestinal Intolerance in Ethiopian Patients with Type 2 Diabetes Mellitus. | Pharmgenomics Pers Med | 2024 | 38715682 | PubTator, text mining | PubMed |
| The full spectrum of SLC22 OCT1 mutations illuminates the bridge between drug transporter biophysics and pharmacogenomics. | Mol Cell | 2024 | 38703769 | PubTator, text mining | PubMed |
Survey of Pharmaceutical Industry's Best Practices around In Vitro Transporter Assessment and Implications for Drug Development: Considerations from the International Consortium for Innovation and Quality for Pharmaceutical Development Transporter Working Group. | Drug Metab Dispos | 2024 | 38697852 | PubTator, text mining | PubMed |
| Immunotherapy and drug sensitivity predictive roles of a novel prognostic model in hepatocellular carcinoma. | Sci Rep | 2024 | 38664521 | PubTator, text mining | PubMed |
| Inhibition of human drug transporter activities by succinate dehydrogenase inhibitors. | Chemosphere | 2024 | 38663675 | PubTator, text mining | PubMed |
| Bioisosteric analogs of MDMA with improved pharmacological profile. | bioRxiv | 2024 | 38645142 | PubTator, text mining | PubMed |
| A prognostic model built on amino acid metabolism patterns in HPV-associated head and neck squamous cell carcinoma. | Arch Oral Biol | 2024 | 38626700 | PubTator, text mining | PubMed |
| THOC7-AS1/OCT1/FSTL1 axis promotes EMT and serves as a therapeutic target in cutaneous squamous cell carcinoma. | J Transl Med | 2024 | 38605354 | PubTator, text mining | PubMed |
| Targeted mutagenesis of negatively charged amino acids outlining the substrate translocation path within the human organic cation transporter 3. | Biochem Pharmacol | 2024 | 38580166 | PubTator, text mining | PubMed |
| A senescence restriction point acting on chromatin integrates oncogenic signals. | Cell Rep | 2024 | 38568812 | PubTator, text mining | PubMed |
| Identification of ADME genes polymorphic variants linked to trastuzumab-induced cardiotoxicity in breast cancer patients: Case series of mono-institutional experience. | Biomed Pharmacother | 2024 | 38547766 | PubTator, text mining | PubMed |
| Structural insights into human organic cation transporter 1 transport and inhibition. | Cell Discov | 2024 | 38485705 | PubTator, text mining | PubMed |
| Genetic diversity of variants involved in drug response among Tunisian and Italian populations toward personalized medicine. | Sci Rep | 2024 | 38462643 | PubTator, text mining | PubMed |
| Medicinal Polypharmacology in the Clinic - Translating the Polypharmacolome into Therapeutic Benefit. | Pharm Res | 2024 | 38366233 | PubTator, text mining | PubMed |
| Interaction and Transport of Benzalkonium Chlorides by the Organic Cation and Multidrug and Toxin Extrusion Transporters. | Drug Metab Dispos | 2024 | 38307853 | PubTator, text mining | PubMed |
| A genome-wide association study identifies 25(OH)D3-associated genetic variants in the prediabetic Chinese population. | Endocrine | 2024 | 38291318 | PubTator, text mining | PubMed |
| Evaluation of the drug-drug interaction potential of brigatinib using a physiologically-based pharmacokinetic modeling approach. | CPT Pharmacometrics Syst Pharmacol | 2024 | 38288787 | PubTator, text mining | PubMed |
| Tailoring Type II Diabetes Treatment: Investigating the Effect of 5-HTT Polymorphisms on HbA1c Levels after Metformin Initiation. | J Diabetes Res | 2024 | 38288388 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6580/papers?page=8